Sheri Smith

824 citations
9 papers · 669 · h-index 8

Impact in

Papers in

Co-authors
Wei Lemaire (6 shared papers)David L. Williams (6 shared papers)Craig W. Lindsley (6 shared papers)Philip R. Tiller (6 shared papers)Cyrille Sur (6 shared papers)Gene G. Kinney (5 shared papers)P. Jeffrey Conn (3 shared papers)Mark E. Duggan (3 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (1 paper)ChemMedChem (1 paper)Drug Metabolism and Disposition (1 paper)Rapid Communications in Mass Spectrometry (1 paper)
Partner nations
United States

In The Last Decade

Sheri Smith

9 papers receiving 644 citations

Peers

Sheri Smith
Comparison fields: 5 of 68
  • Cellular and Molecular Neuroscience 378
  • Biological Psychiatry 35
  • Spectroscopy 126
  • Biochemistry 53
  • Toxicology 21
Replace Katarzyna Kulig with:
Katarzyna Kulig Poland
Klaus P. Bøgesø Denmark
Hilde Lavreysen Belgium
John A. Monti United States
Jeffrey K. Saelens Switzerland
Samuel T. Christian United States
Joseph T. Strupczewski United States
Matthew J. Valli United States
José M. Cid Belgium
M. Edward Pierson United States
Sheri Smith relative to Katarzyna Kulig Poland Katarzyna Kulig's profile →
Citations per field
00.5×1.5×1.9×
Katarzyna Kulig · 1×
Citations per year

Countries citing papers authored by Sheri Smith

Since Specialization
Citations

This map shows the geographic impact of Sheri Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri Smith more than expected).

Fields of papers citing papers by Sheri Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheri Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri Smith. The network helps show where Sheri Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Sheri Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sheri Smith Line = papers co-authored together Sheri Smith links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models
Journal of Pharmacology and Experimental Therapeutics ·Gene G. Kinney, Julie A. O’Brien, Wei Lemaire, Maryann Burno, Denise Bickel, Michelle K. Clements, Tsing‐Bau Chen, David D. Wisnoski, Craig W. Lindsley, Philip R. Tiller, Sheri Smith, Marlene A. Jacobson, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams
2005244
2
Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of N-(1,3-Diphenyl-1H- pyrazol-5-yl)benzamides That Potentiate Receptor Function in Vivo
Journal of Medicinal Chemistry ·Craig W. Lindsley, David D. Wisnoski, William Leister, Julie A. O’Brien, Wei Lemaire, David L. Williams, Maryann Burno, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, Mark E. Duggan, George D. Hartman, P. Jeffrey Conn, Joel R. Huff
2004149
3
Liquid extraction surface analysis mass spectrometry (LESA‐MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example
Rapid Communications in Mass Spectrometry ·Daniel Eikel, Marissa Vavrek, Sheri Smith, Carol Bason, Suzie Yeh, Walter A. Korfmacher, Jack D. Henion
2011140
4
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors
Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, Kenneth L. Arrington, Carolyn A. Buser, Patrice A. Ciecko, Kathleen Coll, Christine Fernandes, George D. Hartman, William F. Hoffman, Joseph J. Lynch, Rosemary C. McFall, Keith Rickert, Romi Singh, Sheri Smith, Kenneth A. Thomas, Bradley K. Wong
200346
5
Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides
ChemMedChem ·Craig W. Lindsley, Zhijian Zhao, William Leister, Julie L. O'Brien, Wei Lemaire, David L. Williams, Tsing‐Bau Chen, Raymond S.L. Chang, Maryann Burno, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, Douglas J. Pettibone, Philip R. Tiller, Sheri Smith, Nancy N. Tsou, Mark E. Duggan, P. Jeffrey Conn, George D. Hartman
200636
6
Discovery of GlyT1 inhibitors with improved pharmacokinetic properties
Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, David D. Wisnoski, William Leister, Julie L. O'Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, Christopher R. Gibson, Bennett Ma, Stacey L. Polsky-Fisher, Craig W. Lindsley, George D. Hartman
200919
7
Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors
Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, William Leister, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, Craig W. Lindsley, S. E. Wolkenberg
200918
8
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides
Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, S. E. Wolkenberg, Craig W. Lindsley
200614
9
Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
Drug Metabolism and Disposition ·Suresh K. Balani, Mark E. Goldman, L R Kauffman, S Varga, J A O'Brien, Sheri Smith, Timothy Olah, Harri G. Ramjit, Terry W. Schorn, Steven M. Pitzenberger
19933

About Sheri Smith

Sheri Smith is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Oncology, Biochemistry and Pharmacology, having authored 9 papers that have together received 669 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Amino Acid Enzymes and Metabolism (3 papers), Receptor Mechanisms and Signaling (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Phosphodiesterase function and regulation (1 paper) and Neuroendocrine regulation and behavior (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (378 citations), Biological Psychiatry (35 citations), Spectroscopy (126 citations), Biochemistry (53 citations) and Toxicology (21 citations). Sheri Smith has collaborated with scholars based in United States. Frequent co-authors include Wei Lemaire, David L. Williams, Craig W. Lindsley, Philip R. Tiller, Cyrille Sur, Gene G. Kinney, P. Jeffrey Conn, Mark E. Duggan, Julie A. O’Brien and Maryann Burno. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ChemMedChem, Drug Metabolism and Disposition and Rapid Communications in Mass Spectrometry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna KuligBreakdown of academic impact, for papers by Klaus P. BøgesøBreakdown of academic impact, for papers by Hilde LavreysenBreakdown of academic impact, for papers by John A. MontiBreakdown of academic impact, for papers by Jeffrey K. SaelensBreakdown of academic impact, for papers by Samuel T. ChristianBreakdown of academic impact, for papers by Joseph T. StrupczewskiBreakdown of academic impact, for papers by Matthew J. ValliBreakdown of academic impact, for papers by José M. CidBreakdown of academic impact, for papers by M. Edward Pierson